Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

AgomAb is developing molecular therapies for the regeneration of damaged tissues. Our unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.The AgomAb team has selected the most promising lead antibodies and continues to generate preclinical ...
AgomAb is developing molecular therapies for the regeneration of damaged tissues. Our unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.The AgomAb team has selected the most promising lead antibodies and continues to generate preclinical data that support the use of these antibodies in fibrotic, inflammatory, autoimmune and degenerative diseases. We are committed to advancing these molecules into clinical development.

List your booth number for exhibitions, ask us